News and Trends 19 Aug 2022 Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy …including non-small cell lung cancer, metastatic urothelial cancer and gastrointestinal cancers. Kerry Blanchard, chief executive officer at Everest Medicines, said: “We welcome the opportunity to restructure our partnership with Gilead,… August 19, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 Lutris Pharma radiation trial brings positive results for breast cancer patients Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD) have been positive. Lutris Pharma, based in Israel, is a biopharma company focused on improving… September 8, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 10 Jun 2024 ASCO 2024: The latest advances in oncology clinical trials …cancers including ovarian, liver, colorectal, pancreatic, bowel, and breast cancer, by 20%, according to the Case Western Reserve University in Ohio. Still, more research is needed to prove this. Cancer… June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 Apr 2025 The future of NSCLC treatment: what’s in store for the therapeutic space? …a higher risk of the cancer coming back, an adjuvant treatment – an additional cancer therapy to lower the risk of cancer recurrence – such as chemotherapy and immunotherapy, is… April 30, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Dec 2024 The rise of cancer vaccines: A new era in immunotherapy …cancer vaccines: Novel Breast Cancer Vaccine – Baylor Scott & White Health Biopolymer Cancer Vaccine Technology – Griffith University Vaccines to Mobilize B Cells for Cancer – University of Toronto… December 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Jul 2022 The race to uncloak cancer with liquid biopsies …May 2022 for the capture and harvest of CTCs from the blood of patients with metastatic breast cancer for subsequent analysis. Metastatic breast cancer is heterogenous and requires constant monitoring… July 27, 2022 - 10 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2022 Therabest and Glycotope to assess breast cancer combination treatment …immuno-cytokine, GT-00AxIL15 in triple-negative breast cancer (TNBC) patients. NK (natural killer) cell therapies from various cell sources have demonstrated exciting results in early clinical trials and are rapidly becoming powerful… December 13, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Feb 2020 Meet 20 European Immuno-Oncology Companies that are Fighting Cancer …company’s lead candidate, an ADC for the treatment of triple-negative breast cancer, lung, and ovarian cancer, is expected to reach phase I in 2020. Images via Elena Resko & Shutterstock.com… February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
In Depth 26 Mar 2025 A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations …investigated. Noteworthy CDK inhibitors currently in development PF-07104091 Developer: Pfizer Target: CDK2 Indication: Hormone receptor-positive (HR+), HER2-negative advanced/metastatic breast cancer, ovarian cancer, small cell lung cancer Stage: Multiple phase 1… March 26, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Health Awareness Days …Stomach Cancer Awareness Month US Mouth Cancer Action Month UK Pancreatic Cancer Awareness Month UK Lung Cancer Awareness Month UK COPD Awareness Month US National Diabetes Month US C. difficile… November 24, 2022 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2024 The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond …Molecular Imaging, has had a great impact on the market, expanding Lantheus’ product portfolio to include breast cancer, in addition to its existing focus on prostate cancer. This diversification strengthens… September 26, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 12 Mar 2025 Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next …used to treat advanced melanoma, a type of skin cancer. It has since been authorized to treat kidney cancer, colorectal cancer, and non-small cell lung cancer (NSCLC). Often, Yervoy is… March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email